NCT02269397View on ClinicalTrials.gov

Proof of Principle for a Diagnostic Blood Test of Recurrent Seizures

CompletedOBSERVATIONAL
Enrollment

371

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

July 14, 2015

Study Completion Date

December 6, 2018

Conditions
Epilepsy
Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

University of Pennsylvania

OTHER

lead

Cognizance Biomarkers, LLC

INDUSTRY

NCT02269397 - Proof of Principle for a Diagnostic Blood Test of Recurrent Seizures | Biotech Hunter | Biotech Hunter